Miller Steve
Officer at CPRX
- Sold, on record
- $13.2M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Aug 26, 2025
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CPRXCATALYST PHARMACEUTICALS, INC.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice CPRXNoticeDec 5, 2023 2023
Filed to sell 40,000 shares ($570k)
Miller Steve, Officer
No 10b5-1 plan0.4x usual sizeFiling
- 2 Form 4 sale CPRXNo planDec 5, 2023 same day
Sold 40,000 shares at $14.24 ($570k)
Miller Steve, Chief Op. & Scientific Officer
No 10b5-1 planSold 5.8% of holdings ($9.8M position)647,457 shares left0.4x usual sizeFollows a Form 144Filing
- 3 Form 144 notice CPRXNoticeAug 20, 2024 +259 days
Filed to sell 150,000 shares ($3.1M)
Miller Steve, Officer
No 10b5-1 plan1.5x usual sizeFiling
- 4 Form 4 sale CPRXNo planAug 20, 2024 same day
Sold 150,000 shares at $20.35 ($3.1M)
Miller Steve, Chief Op. & Scientific Officer
No 10b5-1 planSold 18.2% of holdings ($16.8M position)675,124 shares left1.5x usual sizeFollows a Form 144Filing
- 5 Form 144 notice CPRXNoticeDec 10, 2024 +112 days
Filed to sell 50,000 shares ($1.1M)
Miller Steve, Officer
No 10b5-1 planFirst sale on recordFiling
- 6 Form 4 sale CPRXNo planDec 10, 2024 same day
Sold 50,000 shares at $21.93 ($1.1M)
Miller Steve, Chief Op. & Scientific Officer
No 10b5-1 planSold 6.8% of holdings ($16.2M position)686,996 shares leftFirst sale on recordFollows a Form 144Filing
- 7 Form 144 notice CPRXNoticeAug 26, 2025 +259 days
Filed to sell 115,000 shares ($2.3M)
Miller Steve, Officer
No 10b5-1 plan2.3x usual sizeFiling
- 8 Form 4 sale CPRXNo planAug 26, 2025 same day
Sold 115,000 shares at $20.28 ($2.3M)
Miller Steve, Chief Op. & Scientific Officer
No 10b5-1 planSold 10.8% of holdings ($21.6M position)949,663 shares left2.3x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2025 | Aug 28, 2025 | CPRX | Chief Op. & Scientific Officer | Form 4 sale | 115,000 | $2.3M | 10.8% | No plan | SEC |
| Aug 26, 2025 | Aug 26, 2025 | CPRX | Officer | Form 144 notice | 115,000 | $2.3M | Notice | SEC | |
| Dec 10, 2024 | Dec 11, 2024 | CPRX | Chief Op. & Scientific Officer | Form 4 sale | 50,000 | $1.1M | 6.8% | No plan | SEC |
| Dec 10, 2024 | Dec 10, 2024 | CPRX | Officer | Form 144 notice | 50,000 | $1.1M | Notice | SEC | |
| Aug 20, 2024 | Aug 22, 2024 | CPRX | Chief Op. & Scientific Officer | Form 4 sale | 150,000 | $3.1M | 18.2% | No plan | SEC |
| Aug 20, 2024 | Aug 20, 2024 | CPRX | Officer | Form 144 notice | 150,000 | $3.1M | Notice | SEC | |
| Dec 5, 2023 | Dec 7, 2023 | CPRX | Chief Op. & Scientific Officer | Form 4 sale | 40,000 | $570k | 5.8% | No plan | SEC |
| Dec 5, 2023 | Dec 5, 2023 | CPRX | Officer | Form 144 notice | 40,000 | $570k | Notice | SEC | |
| Nov 23, 2022 | Nov 23, 2022 | CPRX | Chief Operating Officer | Form 4 sale | 100,000 | $1.6M | 15.3% | Plan not stated | SEC |
| Sep 13, 2022 | Sep 15, 2022 | CPRX | Chief Operating Officer | Form 4 sale | 107,933 | $1.8M | 14.2% | Plan not stated | SEC |
| Aug 18, 2022 | Aug 19, 2022 | CPRX | Chief Operating Officer | Form 4 sale | 150,000 | $2M | 16.5% | Plan not stated | SEC |
| Aug 25, 2021 | Aug 26, 2021 | CPRX | Chief Operating Officer | Form 4 sale | 80,000 | $445k | 9.7% | Plan not stated | SEC |
| Aug 13, 2021 | Aug 17, 2021 | CPRX | Chief Operating Officer | Form 4 sale | 40,963 | $249k | 5.5% | Plan not stated | SEC |